Program Tracks

During the educational activities you will be able to asses current knowledge presented by world’s leading scientists who discuss the latest developments in kidney research, spanning from current findings of interest to the renal community, to basic science, clinical nephrology, acute and chronic kidney disease, hemodialysis and peritoneal dialysis management, kidney transplantation, and epidemiology.

Attending the educational activities will enhance your professional and personal development. It will allow you to integrate and relate clinical practice with research and innovation, which will lead you to improved patient outcomes and quality of life.


Sessions

Session:

Implications of COVID-19 for kidney transplantation: the organ supply

The global spread of COVID-19 has led to changes in routine clinical care in order to prevent nosocomial transmission of SARS-CoV2. One area this is impacted is kidney transplantation, where there is a particular need to avoid transmission of the virus from donors to immunosuppressed recipients. This session aims to describe the impact of COVID-19 on the supply of living and deceased donor kidneys.  

Watch Now...
Speakers:
  • Syed A Husain, MD, MPH, FASN
    Columbia University, New York, NY
Session:

Invasive vs. non-invasive management of heart disease in CKD

Watch Now...
Speakers:
  • Ziad A. Ali, MD
    Columbia University, New York, NY
Session:

Lifelong legacy of childhood kidney disease

This presentation makes the case that focusing on childhood kidney disorders and the risk for such disorders will improve the identification and care of adults with kidney disease. By focusing on kidney disease in childhood, cost-effective solutions may be reached because treating the disease early and preemptively may avert later more advanced CKD. Expectations depend on the identification of those at risk, and the availability of care and management. Treating children who have AKI and CKD who may require long-term medication or who require RRT can be effective in mitigating the burden of kidney disease in adulthood. This presentation will discuss who these children are and how they might be followed.  

Watch Now...
Speakers:
  • Julie Ingelfinger, MD
    Harvard Medical School, Boston, MA
Session:

Nutrition in CKD guidelines update overview: what is new and what do we change?

The session will explain the guideline development process and the benefits of multidisciplinary collaboration between the National Kidney Foundation and the Academy of Nutrition and Dietetics to produce global evidence-based nutrition guidelines for patients with chronic kidney disease. It will also help the audience recognize the differences between the KDOQI Nutrition 2000 and KDOQI Nutrition 2020 recommendations.  

Watch Now...
Speakers:
  • T. Alp Ikizler, MD
    Vanderblit University Medical Center, Nashville, TN
Session:

Pandemic preparedness and response of dialysis facilities: the COVID-19 experience

This lecture will review the effects of  COVID-19 infection on kidney function and describe the risk of SARS Co-V-2 infection in dialysis patients.

Watch Now...
Speakers:
  • Alan Kliger, MD
    Yale University, New Haven, CT
Session:

Plasmapheresis as a therapy for Alzheimer’s disease

In this lecture there will be a review of the neuropathology of Alzheimer's disease (AD), along with a discussion of current treatments in development. The effects of hemodialysis on AD biomarkers and pathology will be discussed. In addition, there will be a discussion of the recent results of the AMBAR phase 2b/3 clinical trial of plasma exchange with albumin replacement as a treatment for AD.  

Watch Now...
Speakers:
  • Thomas Wisniewski, MD
    New York University School of Medicine, New York, NY
Session:

Sleep apnea as a cardio-renal risk factor in CKD and in ESKD

Upon the completion of this session, participants should be better able to identify patients affected by sleep apnea in CKD, describe the risk for death and cardiovascular events in CKD patients, and make treatment decisions for their patients.

Watch Now...
Speakers:
  • Carmine Zoccali, MD
    Institute of Clinical Physiology of Pisa, National Research Center (IFC-CNR), Reggio Calabria Unit, Italy
Session:

The future of nephrology: challenges of epidemiology and care of CKD

The future of nephrology depends on improved understanding epidmiology, improved clinical research participation and translation of understandings to improve care. Globally, the nephrology community has an opportunity to improve patient outcomes through advocacy, research and education. This talk focuses on some of the current disparities in access to care( including dialysis) and research as well as offering a paradigm and framework in which to conceptualize these issues.  

Watch Now...
Speakers:
  • Adeera Levin, MD, FRCPC, FACP, CM
    University of British Columbia, Vancouver, BC, Canada
Session:

Testing of patients and healthcare workers (routine testing, surveillance testing, symptomatic testing): the MGH experience

In this session Dr. Thadhani reviews how testing for SARS-CoV-2 evolved in the US, with a specific emphasis on how different test characteristics were needed depending on how they are being used. Sensitivity and Ro are highlighted in modeling how frequently testing should be done to contain the spread of SARS-CoV-2. Finally, there is a review of the spread of specific variants and how testing is critical to map the spread of variants.  

Watch Now...
Speakers:
  • Ravi Thadhani, MD, MPH
    Harvard Medical School/Mass General Hospital, Boston, MA
Session:

Transitioning from pediatric to adult health care

Treating disease early and preemptively may avert later more advanced CKD. Expectations depend on the identification of those at risk, and the availability of care and management. Treating children who have AKI and CKD who may require long-term medication or who require RRT can be effective in mitigating the burden of kidney disease in adulthood. This presentation will discuss who these children are and how they might be followed.  

Watch Now...
Speakers:
  • Ana Catalina Alvarez Elias, MD, MSc
    Hospital for Sick Kids, Toronto, ON Canada
  • Maria E Ferris, MD, MPH, PhD
    UNC at Chapel Hill, Chapel Hill, NC